Ulinastatin protects brain against cerebral ischemia/reperfusion injury through inhibiting MMP-9 and alleviating loss of ZO-1 and occludin proteins in mice.

Authors:
Xiao-fang Li
Xiao-fang Li
FCM Institute
China
Cong Zhang
Cong Zhang
Shandong Normal University
China
Li-na Wang
Li-na Wang
Peking University Third Hospital
China
Ye Zhang
Ye Zhang
National Cancer Center/Cancer Hospital
Bethesda | United States
Ting-Ting He
Ting-Ting He
Nanjing University
China
Xing-yuan Zhu
Xing-yuan Zhu
Pediatric Research Institute of Children's Hospital

Exp Neurol 2018 04 30;302:68-74. Epub 2017 Dec 30.

Department of Interventional Treatment, Henan Provincial People's Hospital, Zhengzhou, Henan, China. Electronic address:

Background: The effects of Ulinastatin (UTI) on the blood-brain barrier (BBB) in the acute phase of cerebral ischemia/reperfusion (I/R) are not clear. This study was to investigate the potential protective effects of UTI on the BBB and the underlying mechanisms.

Methods: Male CD-1 mice were subjected to transient middle cerebral artery occlusion (tMCAO) and randomly assigned to four groups: Sham (sham-operated), tMCAO (tMCAO+0.9% saline), UTI-L (tMCAO+UTI 1500U/100g) and UTI-H (tMCAO+UTI 3000U/100g) group. UTI was administered immediately after reperfusion in the UTI-L and UTI-H groups. At 24h after reperfusion, the neurological deficit, brain water content, and infarct volume were determined. Western blot and quantitative reverse transcription polymerase chain reaction (qRT-PCR) were used to examine the expression of matrix metalloproteinase (MMP)-9, Zonula occludens-1 (ZO-1) and occludin in ischemic cerebral cortex. The integrity of the BBB was assessed by the leakage of Evans blue.

Results: Compared with tMCAO group, both UTI-L and UTI-H groups showed significantly (P<0.001) ameliorated the neurological deficit (2.00±0.71 and 1.60±0.55 vs. 4.60±0.55), lessened brain water content (82.99%±0.21% and 82.05%±0.59% vs. 84.28%±0.0.57%) and decreased the infarct volume (38.52%±1.72% and 24.78%±1.20% vs. 49.48%±1.93%). In addition, significantly (P<0.001) decreased expression of MMP-9 (0.48±0.06 and 0.37±0.05 vs.0.76±0.10 for protein and 2.88±0.23 and 2.17±0.16 vs. 3.90±0.24 for mRNA) and alleviated loss of ZO-1 (0.19±0.04 and 0.24±0.05 vs. 0.25±0.03) and occludin (0.74±0.08 and 0.87±0.07 vs. 0.94±0.06) proteins were observed in both UTI-L and UTI-H groups.

Conclusion: UTI protects the brain against ischemic injury potentially via down-regulating the expression of MMP-9 and alleviating loss of ZO-1 and occludin proteins to restore the BBB permeability.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.expneurol.2017.12.016DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
April 2018
9 Reads
4.700 Impact Factor

Publication Analysis

Top Keywords

uti-l uti-h
8
zo-1 occludin
8
cerebral ischemia/reperfusion
8
uti-h groups
8
group uti
4
uti administered
4
3000u/100g group
4
brain water
4
uti-h tmcao+uti
4
tmcao+uti 3000u/100g
4
administered reperfusion
4
reperfusion uti-l
4
groups 24h
4
24h reperfusion
4
neurological deficit
4
1500u/100g uti-h
4
deficit brain
4
reperfusion neurological
4
tmcao+uti 1500u/100g
4
artery occlusion
4

Similar Publications